Phase 3 Infectious Disease Study: 42% Cohort Enrollment Across 36 States in Just 8 Weeks

Science 37 was the top enrolling site, contributing 42% of total participants across 36 states in just 8 weeks for the study's immunocompromised cohort. Science 37 achieved a >90% visit completion rate across over 700 in-home visits, and notably, included 23% minority representation.